全文获取类型
收费全文 | 1051篇 |
免费 | 127篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 36篇 |
妇产科学 | 4篇 |
基础医学 | 130篇 |
口腔科学 | 33篇 |
临床医学 | 63篇 |
内科学 | 249篇 |
皮肤病学 | 18篇 |
神经病学 | 83篇 |
特种医学 | 31篇 |
外科学 | 210篇 |
综合类 | 20篇 |
一般理论 | 1篇 |
预防医学 | 100篇 |
眼科学 | 4篇 |
药学 | 47篇 |
中国医学 | 1篇 |
肿瘤学 | 116篇 |
出版年
2019年 | 11篇 |
2018年 | 9篇 |
2016年 | 14篇 |
2015年 | 18篇 |
2014年 | 18篇 |
2013年 | 20篇 |
2012年 | 50篇 |
2011年 | 36篇 |
2010年 | 20篇 |
2009年 | 12篇 |
2008年 | 29篇 |
2007年 | 32篇 |
2006年 | 45篇 |
2005年 | 32篇 |
2004年 | 35篇 |
2003年 | 40篇 |
2002年 | 22篇 |
2001年 | 32篇 |
2000年 | 21篇 |
1999年 | 22篇 |
1997年 | 11篇 |
1995年 | 12篇 |
1994年 | 9篇 |
1993年 | 10篇 |
1992年 | 21篇 |
1991年 | 22篇 |
1990年 | 31篇 |
1989年 | 16篇 |
1988年 | 17篇 |
1987年 | 18篇 |
1986年 | 27篇 |
1985年 | 28篇 |
1984年 | 26篇 |
1983年 | 18篇 |
1982年 | 13篇 |
1981年 | 14篇 |
1980年 | 9篇 |
1979年 | 18篇 |
1978年 | 16篇 |
1977年 | 13篇 |
1976年 | 16篇 |
1975年 | 19篇 |
1974年 | 19篇 |
1973年 | 16篇 |
1971年 | 18篇 |
1970年 | 29篇 |
1969年 | 9篇 |
1968年 | 20篇 |
1967年 | 25篇 |
1966年 | 23篇 |
排序方式: 共有1179条查询结果,搜索用时 46 毫秒
91.
The response of cerebral metastases in small cell lung cancer to systemic chemotherapy 总被引:2,自引:0,他引:2
C J Twelves R L Souhami P G Harper C M Ash S G Spiro H M Earl J S Tobias H Quinn D M Geddes 《British journal of cancer》1990,61(1):147-150
Although small cell lung cancer (SCLC) is very chemosensitive, cerebral metastases are treated with radiotherapy in the belief that they are protected from chemotherapy by the blood-brain barrier (BBB). The validity of this assumption has not been tested in clinical practice. In a randomised trial of treatment in 610 patients with SCLC, 19 patients who had symptomatic cerebral metastases at presentation were treated initially with chemotherapy, and cranial irradiation withheld. Chemotherapy was cyclophosphamide 1 g m-2 i.v. day 1, vincristine 2 mg i.v. day 1 and etoposide 100 mg tds p.o. days 1-3, repeated every 21 days, with response assessed objectively by computerised tomography (CT) or radionuclide brain scan, and by clinical examination. A post-chemotherapy scan was obtained in 14 patients, eight of whom achieved a partial remission and one a complete remission of the cerebral metastases. The radiologically proven responses were sustained and accompanied by rapid neurological improvement. Of the remaining five patients who were assessed by clinical examination alone, one had improved neurological function after chemotherapy. The response rate for SCLC cerebral metastases treated with chemotherapy was therefore 10/19 (53%). Chemotherapy has the advantage over cranial irradiation of simultaneously treating both cerebral metastases and extracranial disease. The place of chemotherapy in the management of cerebral metastases in this and other chemosensitive tumours should be reconsidered since these findings indicate that the BBB does not prevent response to chemotherapy. 相似文献
92.
Diagnosis and pitfalls in the treatment of parotid tumors 总被引:1,自引:0,他引:1
R H Spiro 《Seminars in surgical oncology》1991,7(1):20-24
Any swelling near the ear is best considered a parotid neoplasm until proved otherwise. The diagnosis is primarily based on the clinical examination. Imaging studies are best reserved for patients who present with palate or tonsil swellings, which must be distinguished from parapharyngeal or minor salivary gland tumors. Almost all benign, and most malignant parotid tumors can be resected with preservation of the facial nerve. Aspiration biopsy can add useful information, but is not essential for treatment planning as the extent of the surgical procedure is primarily determined by the extent of the tumor. Survival rates in patients with malignant tumors are most significantly influenced by tumor stage. Results seem to have improved in recent years, possibly because we are treating a larger proportion with favorable lesions. Another factor may relate to the enhancement of locoregional control now achieved with postoperative radiotherapy, particularly in patients with Stage III or IV tumors. 相似文献
93.
H Spiro 《Clinics in Geriatric Medicine》1991,7(2):387-394
Who are the old? Is age a category, like sex? Does just getting to a certain age justify certain rewards and certain limits? Is there a role for old physicians working in a hospital? What should age be a criterion for? There are no firm answers, but there should be more discussion. 相似文献
94.
Paul Spiro 《Naunyn-Schmiedeberg's archives of pharmacology》1923,100(1-2):38-50
Ohne Zusammenfassung 相似文献
95.
96.
Treatment of human glomerular basement membrane (GBM) with 4 M guanidine HCl resulted in a preferential extraction of noncollagenous components including laminin, fibronectin, entactin, and heparan sulfate proteoglycan, whereas effective solubilization of type IV collagen required exposure to denaturing solvents in the presence of reducing agents. The guanidine HCl-solubilized constituents were identified by immunochemical procedures after resolution by polyacrylamide gel electrophoresis, CL-6B filtration, and DEAE-cellulose chromatography. Two immunologically related heparan sulfate proteoglycans (Mr approximately 350,000 and 210,000) were observed by electrophoresis, with the higher-molecular-weight form being predominant. An examination of the two proteoglycans after heparitinase digestion or chemical deglycosylation indicated that heparan sulfate chains and other carbohydrate units are attached to core proteins with Mr approximately 140,000 and 110,000, respectively. Radioimmunoassays indicated that human diabetic GBM contained significantly lower (P less than .005) amounts of heparan sulfate proteoglycan and laminin with average values that were 30 and 60%, respectively, of nondiabetic controls; the fibronectin content of the diabetic GBM, however, was not significantly different from the normal. These findings, together with previous studies showing increases in GBM collagen, indicate that an alteration in the macromolecular architecture of this basement membrane occurs in diabetes that may be responsible for the filtration defect and the ultimate glomerular occlusion. 相似文献
97.
G Koren Y Zarfin D Maresky T E Spiro S M MacLeod 《Pediatric pharmacology (New York, N.Y.)》1986,5(4):287-292
We studied 12 newborn infants (gestational ages 26-39 wk [mean +/- SD, 30.6 +/- 4.7]; birth weight 640-2700 g, [mean, 1,322 +/- 688]; postnatal age 1-24 days [mean, 9.6 +/- 8.5]) who received clindamycin phosphate for suspected or proven necrotizing enterocolitis (ten patients) or suspected anaerobic septicemia (two patients) in doses of 3.2-11 mg/kg every six hours. Range of mean serum concentration of clindamycin at steady state was between 12.7 and 40 micrograms/ml (therapeutic range = 2-10 micrograms/ml). High concentrations could be attributed to elimination T1/2 (6.3 +/- 2.1 hr) 100% longer than in older children or adults. Clindamycin clearance (61.6 +/- 31.6 hr ml/kg/hr) was lower than in older children or adults. Because of the observed prolongation in T1/2 and correspondingly lower clearance, the IV dose of clindamycin in newborn infants should be reduced to 15-20 mg/kg/day given in four daily doses. 相似文献
98.
D. C. Damin G. C. Tolfo M. A. Rosito B. L. Spiro L. M. Kliemann 《Techniques in coloproctology》2010,14(2):133-139
Background
To assess the feasibility of the sentinel lymph node procedure in patients with rectal cancer extending to the anal canal. 相似文献99.
Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer. 总被引:1,自引:0,他引:1
D W Miles H M Earl R L Souhami P G Harper R Rudd C M Ash L James C W Trask J S Tobias S G Spiro 《Journal of clinical oncology》1991,9(2):280-285
A weekly, intensive chemotherapy regimen has been used to treat 70 patients with small-cell lung cancer (SCLC). Forty-five patients had limited disease (LD) and 25 extensive disease (ED) with good prognostic features. The regimen consisted of cisplatin 50 mg/m2 intravenously (IV) day 1 and etoposide 75 mg/m2 IV days 1 and 2, alternating weekly with ifosfamide 2 g/m2 IV day 8 and doxorubicin 25 mg/m2 IV day 8, for a total of 12 weeks. Dose modifications were made according to defined hematologic criteria. Responding patients with limited disease subsequently received mediastinal radiotherapy. Overall response to chemotherapy was 91% with a complete response (CR) rate of 50%. Forty-five patients with limited disease (LD) achieved an overall response rate of 91% with a CR rate of 51%, and 25 patients with extensive disease (ED) achieved an overall response rate of 92% with a CR rate of 48%. Median survival for the whole group was 54 weeks (LD, 58 weeks; ED, 42 weeks). Hematologic toxicity was predictable, without the wide fluctuations in WBC count seen in conventional 3-weekly regimens. In all, one quarter of treatment courses were delayed, most frequently because of leukopenia. Dose reductions were required in 63% of cases. The average delivered dose intensity was calculated and shown to be 73% of projected. Nonhematologic toxicity was mild with nausea and vomiting being the most common. This weekly schedule of chemotherapy has proved to be active and well tolerated and is currently being compared with conventional 3-weekly chemotherapy in a randomized study. 相似文献
100.
Dr. S. Ginsberg Dr. G. Spiro 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》1914,88(1):44-59
Ohne ZusammenfassungNach einem am 23. X. 13 in der Berl. ophth. Ges. gehaltenen Vortrag. 相似文献